icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
MASS BALANCE, METABOLIC PROFILE, AND THE ROLE OF HEPATIC AND BACTERIAL ENZYMES IN THE METABOLISM OF THE HCV POLYMERASE INHIBITOR, DELEOBUVIR
 
 
  Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
 
R Sane1, L-Z Chen1, E Philip1, S Regan1, H Maw1, H Yu1, A Mathur1, Y Li1, DA Mandarino2, JP Sabo11Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 2Covance Clinical Research Unit Inc., Madison, WI, USA Rucha Sane rucha.sane@boehringer-ingelheim.com

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif